Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3928studies shown
Showing 2,926-2,950 of 3,928
OngoingEUCTR 2007-006914-41

Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma

This study is looking at whether Cipralex 10 mg can help people with Differential responses to Cognitive Behavioural Analysis System of Psychotherapy versus Escitalopram in chronic major depression with and without early trauma. Participants receive the study medicine Cipralex 10 mg and complete study visits and assessments.

DepressionOther
Countries
Germany
Sponsor
Dept. of Psychiaty, University of Freiburg
Condition
Depression
OngoingEUCTR 2007-000137-19

Metyrapone as additive treatment in patients with major depression

This study is looking at whether Metopiron can help people with unipolar depressive episode without psychotic features according to DSM-IV-TR. Participants receive the study medicine Metopiron and complete study visits and assessments.

DepressionOther
Countries
Netherlands
Sponsor
Leiden University Medical Center
Condition
Depression
OngoingEUCTR 2004-000502-40

A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex...

This study is looking at whether a digital support tool can help people with with cancer in palliative stage of their illness. Suffering from fatigue with or without decreased concentration, depression or drowsiness, who feel their fatigue is severe enough to decre or Elderly.

DepressionOther
Countries
United Kingdom
Sponsor
Southampton University Hospitals Trust
Condition
Depression
OngoingEUCTR 2010-023473-18

Verkehrssicherheit unter Agomelatin

x. Participants receive Valdoxan or Trevilor retard and complete study visits and assessments.

DepressionOther
Countries
Germany
Sponsor
Inn-Salzach-Klinikum gGmbH
Condition
Depression
OngoingEUCTR 2009-010188-18

Effectiveness of Transmural Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain: a randomized placebo-controlled Multi-Centre trial.

This study is looking at whether DULOXETINE can help people with depression, as principal DSM-IV diagnosis combined with chronic pain symptoms as defined bij score of >3 on BPI painlist for at least six weeks or Elderly. Participants receive the study medicine DULOXETINE and complete study visits and assessments.

DepressionOther
Countries
Netherlands
Sponsor
Eli Lilly Nederland
Condition
Depression
OngoingEUCTR 2006-001079-39

Interozeptive Aufmerksamkeit, Hitze-Schwelle und körperliche Symptome bei Patienten mit einer depressiven Episode, vor und nach Behandlung mit Duloxetin. Eine Pilotstudie mittels funktioneller Mag...

This study is looking at whether Duloxetin-Hydrochlorid can help people with Diagnose einer „Major Depression“. Der Gesamtscore der Hamilton-Depressionsskala-17 muß mindestens 15 betragen.

DepressionOther
Countries
Germany
Sponsor
Universitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie
Condition
Depression
OngoingEUCTR 2018-001884-21

A randomised, placebo-controlled, double-blind trial of the antidepressant efficacy of a novel CNS-penetrant P2X7 receptor antagonist, JNJ-54175446, in people with major depressive disorder, an inc...

This study is comparing JNJ-54175446 with placebo for people with depression with an incomplete response to monoaminergic antidepressants and with biomarker profile indicative of inflammation. Participants receive JNJ-54175446 or placebo and complete study visits and assessments.

DepressionOther
Countries
United Kingdom, View results
Sponsor
Cambridgeshire and Peterborough NHS Foundation Trust and University of Cambridge
Condition
Depression
OngoingEUCTR 2009-014056-30

Reconnaissance des expressons faciales émotionnelles chez les patients présentant un épisode dépressif magnétique transcranienne répétée du cortex préfrontal dorsolatéral droit à basse fréquence et...

This study is looking at whether Venlafaxine can help people with depression or Elderly. Participants receive the study medicine Venlafaxine and complete study visits and assessments.

DepressionOther
Countries
France
Sponsor
CHU Clermont-Ferrand
Condition
Depression
OngoingEUCTR 2014-003385-24

The Recall-study: Rivastigmine for ECT-induced Cognitive Adverse effects in Late Life Depression: a multicenter, randomized, double-blind, placebo-controlled, crossover trial

This study is looking at whether Rivastigmine can help people with Interictal delirium during electric convulsive therapy- course or Elderly. Participants receive the study medicine Rivastigmine and complete study visits and assessments.

DepressionOther
Countries
Netherlands
Sponsor
GGZ inGeest, parner VUmc
Condition
Depression
OngoingEUCTR 2021-005992-38

A randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy, safety, tolerability, and pharmacokinetics of single subcutaneous MIJ821 injection in addition to stan...

This study is comparing MIJ821 with placebo for people with Treatment Resistant Depression or Elderly. Participants receive MIJ821 or placebo and complete study visits and assessments.

DepressionOther
Countries
Spain, Poland, View results
Sponsor
Novartis Farmacéutica, S.A.
Condition
Depression
OngoingEUCTR 2022-002757-26

A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy and tolerability of a fixed dose of BH-200 (250 mg BID) i...

This study is comparing Nelivaptan with placebo for people with depression or Elderly. Participants receive Nelivaptan or placebo and complete study visits and assessments.

DepressionOther
Countries
Lithuania, Slovakia, Bulgaria, Germany, Spain
Sponsor
HMNC Holding GmbH
Condition
Depression
OngoingEUCTR 2022-000574-26

A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression

This study is comparing mebufotenin with placebo for people with Treatment-resistant depression. Participants receive mebufotenin or placebo and complete study visits and assessments.

DepressionOther
Countries
Ireland, Czech Republic, Poland, Spain
Sponsor
GH Research Ireland Limited
Condition
Depression
OngoingEUCTR 2022-003743-10

A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, with Open Label Extension, in Patients with Treatment Resistant Depression

This study is comparing Not applicable with Not applicable for people with Treatment-Resistant Depression or Elderly. Participants receive Not applicable or Not applicable and complete study visits and assessments.

DepressionOther
Countries
Germany, Poland, Spain
Sponsor
Beckley Psytech Ltd.
Condition
Depression
OngoingEUCTR 2017-003288-36

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD)

This study is looking at whether PSILOCYBIN can help people with Treatment-Resistant Depression or Elderly. Participants receive the study medicine PSILOCYBIN and complete study visits and assessments.

DepressionOther
Countries
United Kingdom, Czech Republic, Germany, Portugal, Netherlands, Ireland, Denmark, Spain, View results
Sponsor
COMPASS Pathways, Ltd
Condition
Depression
TerminatedEUCTR 2010-020493-42

A Double-blind, Randomized, Placebo-controlled, Multicentre, Relapse-prevention Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder

This study is comparing VORTIOXETINE with placebo for people with Major Depressive Disoder or Children, Under 18. Participants receive VORTIOXETINE or placebo and complete study visits and assessments.

DepressionOther
Countries
Bulgaria, Poland, Latvia, Spain, View results
Sponsor
H. Lundbeck A/S
Condition
Depression
Depression | Clinical Trials | HopeStage Research